Crohn's Disease, Dietary Modification, Inflammatory Bowel Diseases
Conditions
Brief summary
This clinical study is designed to evaluate the effect of two dietary patterns, Mediterranean diet and the specific carbohydrate diet on clinical, inflammatory and microbial parameters in patients after pouch surgery and to assess the effect of a personal tailored diet, based on microbial profile, on disease outcomes and generate a predictive model for future interventions.
Detailed description
Increasing evidence exist regarding the role of diet in the pathogenesis of inflammatory bowel diseases. One possible mechanism for the effect of diet on intestinal inflammation is modification of the gut microbial composition. However, the relationship between diet, the microbiome and intestinal inflammation is still vague. The investigators plan to perform a crossover clinical trial. Seventy ulcerative colitis patients post restorative proctocolectomy (pouch) will be randomly allocated into two short-term (one week) dietary interventions, the Mediterranean diet and the specific carbohydrate diet, to assess which diet has the required influence (i.e. increased diversity, decrease in specific pathobionts and increase in anti-inflammatory taxa) on the gut microbiome of each participant. Based on this assessment, each participant will be treated by a personally-tailored diet for up to one year, during which microbial composition, clinical parameters, and quality of life will be assessed.
Interventions
BEHAVIORALMediterranean diet
The Mediterranean diet is rich in complex carbohydrates and fibers and low in animal proteins and fats.
BEHAVIORALSpecific Carbohydrate Diet
The specific carbohydrate diet is a dietary program popular among patients with IBD. The diet allows carbohydrate foods consisting of mono-saccharides only, and excludes di-saccharides and most polysaccharides.
Sponsors
Tel-Aviv Sourasky Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Patients aged 18-75; * Able and willing to sign an informed consent; * Underwent pouch surgery because of refractory UC or Familial Adenomatous Polyposis (FAP) and have a functioning pouch.
Exclusion criteria
* Patients with ileostomy, stricturing disease, use of antibiotics in the month prior to inclusion, significant comorbidity that precludes the patient from participating according to the physicians' judgment, non-Hebrew readers, pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Microbial diversity | 7 days | Shannon α-diversity index |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical score | 7 days | Pouchitis Disease Activity Index (PDAI) |
| C-reactive protein (CRP) | 7 days | Inflammatory marker |
| fecal calprotectin | 7 days | Inflammatory marker |
| Quality of life | 7 days | Inflammatory bowel diseases questionnaire (IBDQ) |
| Microbial composition | 7 days | Change in the abundance of microbial taxa |
Countries
Israel
Contacts
Primary ContactLihi Godny, B.Sc
Outcome results
None listed